Skip to main content
. 2012 Oct 30;5(1):391–397. doi: 10.3892/ol.2012.1005

Table III.

Comparison of bone metastases (n=345) in cases with moderate bone metastases in breast and prostate carcinomas.

Prostate carcinoma (n=161)
Breast carcinoma (n=184)
Skeleton n % n % χ2 P-value
Cervical vertebrae 5 3.11 0 0.00 7.705 0.006
Thoracic vertebrae 39 24.22 34 18.48 1.696 0.193
Lumbar vertebrae 22 13.66 24 13.04 0.029 0.866
Sacrococcyx 14 8.70 8 4.35 2.730 0.098
Ilium 22 13.66 23 12.50 0.103 0.749
Ischium 11 6.83 10 5.43 0.293 0.589
Pubis 7 4.35 4 2.17 1.320 0.251
Ribs 22 13.66 53 28.80 11.908 0.001
Sternum 1 0.62 14 7.61 12.215 0.000
Skull 5 3.11 2 1.09 1.796 0.180
Scapula 0 0.00 4 2.17 5.070 0.024
Collar bone 1 0.62 2 1.09 0.222 0.638
Humerus 5 3.11 3 1.63 0.827 0.363
Femur 7 4.35 3 1.63 2.290 0.130
Radioulnar and tibiofibular 0 0.00 0 0.00 - -
Bones of hands and feet 0 0.00 0 0.00 - -

n, the lesion number of bone metastases. Chi-square test of likelihood ratio was performed to compare the proportions of metastatic bone lesions in breast and prostate carcinomas.